公开(公告)号：US11759471B2

公开(公告)日：2023-09-19

申请号：US16845695

申请日：2020-04-10

Applicant: MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER

Inventor： Shih-Ku Lin ,  Chih-Chiang Yang ,  Tse-Ching Lin ,  Lai-Cheng Chin ,  Pei Hsuan Ho

IPC: A61K31/554 ,  A61K31/5513 ,  A61K31/551 ,  A61K9/28 ,  A61K31/519 ,  A61K31/496 ,  A61K31/38

CPC classification number: A61K31/554 ,  A61K9/28 ,  A61K31/38 ,  A61K31/496 ,  A61K31/519 ,  A61K31/551 ,  A61K31/5513

Abstract: The present invention is concerned with a modified release pharmaceutical composition comprising an effective amount of at least one antipsychotic agent so that the antipsychotic agent(s) are released in such a manner to better accord with physiological and chronotherapeutic requirements of patients.